BioSpace News Archive

The inherited metabolic disorders market lies mostly with the Caucasian and African American populations of world, especially in North America, Europe, Australia, and Africa, followed by the minority populations from South Asia and East A.

The growing awareness about fertility testing across the world is boosting the fertility testing devices market.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global bioprocess technology market was worth US$ 16.5 bn in 2020 and is forecast to reach US$ 78.8 bn by 2031, registering a CAGR of 14.8%.

The growing population worldwide who need wheeled mobility devices is a key underpinning to the expansion of the wheelchairs market.

Brooklyn ImmunoTherapeutics, Inc. announced that on November 18, 2021 it filed with the Securities and Exchange Commission a registration statement on Form S-1 relating to the proposed public offering by certain selling stockholders of up to 6,281,454 shares of Brooklyn’s common stock received in connection with Brooklyn’s acquisition of Novellus, Inc. in July 2021.

BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track Designation for BNT111, an investigational cancer immunotherapy for the potential treatment of advanced melanoma.

CareDx, Inc. today announced its inclusion on the Deloitte Technology Fast 500 ™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America.

Enanta Pharmaceuticals, Inc. today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will participate in two virtual investor conferences in December: Evercore ISI 4th Annual HealthCONx Conference, December 1, 2021 with a fireside chat at 10:30 a.m.

Glaukos Corporation announced that its management is scheduled to virtually participate in the following upcoming investor conferences

Exicure, Inc. today reported financial results for the quarter ended September 30, 2021 and provided an update on corporate progress.